Mechanism of Human Papillomavirus E6-Mediated Repression of P53-Target Gene *Transcription
Thomas, Mary C.
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/84827
Description
Title
Mechanism of Human Papillomavirus E6-Mediated Repression of P53-Target Gene *Transcription
Author(s)
Thomas, Mary C.
Issue Date
2006
Doctoral Committee Chair(s)
Cheng-Ming Chiang
Department of Study
Biochemistry
Discipline
Biochemistry
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Health Sciences, Oncology
Language
eng
Abstract
The mechanism employed by DNA tumor viruses to inhibit p53-dependent transcription is poorly understood. Here we describe a new paradigm for human papillomavirus (HPV) E6 oncoprotein-mediated repression of human p21 WAF1 cyclin-dependent kinase inhibitor gene transcription, independent of its well known role to promote the ubiquitination and degradation of p53. Using both high-risk and low-risk HPV E6 oncoproteins, each representing a class of oncoproteins that is capable of inducing p53 degradation or unable to degrade p53, respectively, we investigated whether these DNA tumor viruses shared a general repression mechanism to inhibit p53-target gene transcription. We used UV-irradiated human fibrosarcoma HT1080 cells treated with proteasome inhibitors (MG132) and in vitro-assembled chromatin templates reconstituted with purified chromatin assembly factors (Acf1 and ISWI), core histones (H2A, H2B, H3, and H4), and a histone chaperone (NAP-1) in order to define the mechanism used by high-risk and low-risk HPV E6 to inhibit p53-dependent transcription. We demonstrate that E6 does not prevent p53 or p300 recruitment to the chromatin, but inhibits p300-mediated acetylation on p53 and nucleosomal core histones. This suppression of protein acetylation requires the E6-interacting regions of p300. Moreover, high-risk HPV E6 mutants unable to interact with p53 or p300, but not deficient in inducing p53 degradation, fail to inhibit p53-mediated activation in vitro and in vivo, indicating that a p53-E6-p300-containing protein complex is critical for repressing p53-target gene activation. It is likely that this mechanism for repressing p53 target gene transcription is common among DNA tumor viruses based on the finding that SV40 large T-antigen, polyomavirus large T-antigen, adenovirus E1B 19K, and human papillomavirus E6 encoded-oncoproteins inhibited p53-dependent chromatin transcription at a step prior to the entry of p300, indicating that oncoprotein incorporation into p53-p300 complex constitutes a major switch for virus-mediated gene regulation through modulation of p300-targeted acetylation on p53 and nucleosomal core histones.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
